Intuitive Surgical Announces $14.4 Million First Quarter Revenue; da Vinci Surgical System Base Surpasses 100

April 25, 2002 at 4:12 PM EDT
MOUNTAIN VIEW, Calif., Apr 25, 2002 (BUSINESS WIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG), the leader in operative surgical robotics, today reported sales of $14.4 million in the first quarter of 2002, up 19% from $12.1 million reported in the first quarter of 2001. Sales growth was driven by increased recurring revenue and higher da Vinci(TM) Surgical System placements. First quarter 2002 recurring revenue, consisting of instruments, accessories, and service was $2.7 million, up 120% from $1.2 million for the same period last year. Intuitive shipped 13 da Vinci(TM) Surgical Systems during the first quarter of 2002 compared to 12 in the first quarter of 2001. During the quarter, Intuitive surpassed 100 cumulative da Vinci(TM) Surgical System placements, ending the quarter with 102.

Total first quarter 2002 systems sales were $11.7 million, instruments and accessories $1.7 million, and service revenue $1.0 million. The following table compares first quarter 2002 revenue and da Vinci(TM) Surgical System placements to the prior year.

                                  Q102         Q101         Incr.
                                  -----        -----        -----
Revenue (Millions)
Systems                           $11.7        $10.9        $ 0.8
Instruments/Accys                 $ 1.7        $ 0.9        $ 0.8
Service                           $ 1.0        $ 0.3        $ 0.7
                                  -----        -----        -----
                                  $14.4        $12.1        $ 2.3
System Population
Placements                          13           12            1
Cumulative Placements              102           52           50
Intuitive's gross margin for the first quarter of 2002 was 48%, compared with 46% for the first quarter of 2001. Gross margin improvement resulted largely from increased sales and improved manufacturing efficiency.

Net loss for the first quarter of 2002 was $5.6 million, compared to a net loss of $3.4 million for the first quarter of 2001. Basic and diluted net loss per share was $0.15, compared to a net loss per share of $0.10 for the first quarter of 2001.

Commenting on the announcement, Lonnie Smith, President and CEO of Intuitive Surgical, said: "We are pleased with our first quarter financial results and revenue growth. During the quarter we successfully moved our headquarters and manufacturing operation to a larger facility. The new facility is now completely operational, providing us with the capacity to support our planned growth into the future. We are proud to have grown our base of da Vinci(TM) Surgical Systems to over 100 during this quarter and our customers continue to increase system usage, which is reflected in the growth of our recurring revenues."

The company will also announce these results at a conference call today at 1:30 PM PT. The dial-in numbers for this call are 888-730-9134 for U.S. calls and 630-395-0027 for international calls. The passcode is ISRG and the meeting leader is Mr. Lonnie Smith.

    About the da Vinci(TM) Surgical System:
The da Vinci(TM) Surgical System consists of a surgeon's viewing and control console having an integrated, high-performance InSite(TM) 3-D vision system, a patient-side cart consisting of three robotic arms that position and precisely maneuver endoscopic instruments and an endoscope, and a variety of articulating EndoWrist(TM) Instruments. By integrating computer-enhanced technology with surgeons' technical skills, Intuitive believes that its System enables surgeons to perform better surgery in a manner never before experienced. The da Vinci(TM) Surgical System seamlessly and directly translates the surgeon's natural hand, wrist and finger movements on instrument controls at the surgeon's console outside the patient's body into corresponding micro-movements of the instrument tips positioned inside the patient through small puncture incisions, or ports.

The statements contained in this release may be deemed to contain "forward-looking statements." Such statements are indicated by words or phrases such as "anticipate," "estimate," "projects," "believes," "intends," "expects" and similar words and phrases. Actual results may differ materially from those expressed or implied in any forward-looking statement as a result of certain risks and uncertainties, including, without limitation, competition and market acceptance of the Company's products, ability to obtain regulatory approvals and third-party reimbursement, ability to raise additional capital and other risks and uncertainties detailed in the Company's Securities and Exchange Commission filings. Prospective investors are cautioned not to place undue reliance on such forward-looking statements.

Intuitive(R), da Vinci(TM), InSite(TM), and EndoWrist(TM) are trademarks of Intuitive Surgical, Inc.

                                              Three months ended
                                         March 31,         March 31,
                                           2002              2001
                                         --------          --------
Sales                                    $ 14,409          $ 12,079
Cost of sales                               7,507             6,563
                                         --------          --------
   Gross profit                             6,902             5,516
Operating costs and expenses:
   Research and development                 4,232             3,231
   Selling, general and administrative      8,785             6,835
                                         --------          --------
      Total operating costs and expenses   13,017            10,066
Loss from operations                       (6,115)           (4,550)
Other income/(expense)                        498             1,143
                                         --------          --------
Net loss                                 $ (5,617)         $ (3,407)
                                         ========          ========
Weighted average shares outstanding
  used to compute net loss per share       36,308            35,401
Loss per share - basic and diluted       $  (0.15)         $  (0.10)
                            (IN THOUSANDS)
                                         March 31,       December 31,
                                           2002              2001
                                         --------          --------
Current assets:
   Cash, cash equivalents and
    short-term investments               $ 56,629          $ 66,661
   Accounts receivable, net                15,492            13,248
   Inventories, net                         6,242             6,182
   Prepaid expenses                         2,888             3,128
                                         --------          --------
      Total current assets                 81,251            89,219
Property and equipment, net                11,124             7,834
Other assets                                3,113             3,308
                                         --------          --------
Total assets                             $ 95,488          $100,361
                                         ========          ========
Liabilities and stockholders' equity
Current Liabilities:
   Accounts payable                      $  9,184          $  8,300
   Accrued compensation and employee
    benefits                                2,506             2,537
   Warranty provision                       1,787             1,831
   Accrued liabilities                      2,085             3,128
   Deferred revenue                         3,624             3,870
   Current portion of notes payable         1,587             1,631
                                         --------          --------
      Total current liabilities            20,773            21,297
Notes payable                               1,282               771
Stockholders' equity
   Common stock                                36                36
   Additional paid-in capital             189,962           188,962
   Deferred compensation                     (670)             (886)
   Accumulated deficit                   (115,987)         (110,370)
   Accumulated other comprehensive
    income                                     92               551
                                         --------          --------
      Total stockholders' equity           73,433            78,293
                                         --------          --------
Total liabilities and
 stockholders' equity                    $ 95,488          $100,361
                                         ========          ========
CONTACT:          Intuitive Surgical
                  Ben Gong, 408/523-2175
                  Sarah Norton, 408/523-2161